Synergizing Activity of ImmTOR Tolerogenic Nanoparticles & an IL-2 Mutein to Expand Antigen- Specific Tregs
Time: 2:00 pm
day: Day One | Track B | Morning
Details:
- Co-administering antigens with ImmTOR nanoparticles encapsulating rapamycin to induce antigen-specific tolerance
- Using ImmTOR combination with a fungal-derived uricase enzyme in Ph3 clinical trials in for the treatment of chronic refractory gout
- Combining ImmTOR with an IL-2 mutein and antigen to induce massive expansion of antigen-specific Tregs in vivo
